Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ ,lcSJ^yr
JbAmud,
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© Rga
*68s|&
G|YNShK4=9
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© {zalfw{+
C6'K)P[p
1.Co-stimulators (or co-stimulating molecules) d7S?"JpV
"7Z-ACyF5
2.NK-kB 3EHB~rL/C
C55Av%-=
3.Immunoglobulin superfamily IGOEqUw*
wC?$P
4.antigen-presenting cell (APC) {y'4&vt<~
)|/%]@` N
5.death domain nH<#MGBS
?,i}Qr [Q
6.CCR and CXCR ^YJ%^P
OA^6l#
7.Lectin (or mitogen) S_TD o
M@o^V(j
8.Clusters of differentiation, CD) }3_>
[{`2FR:Cd
9.B7 family mVFo2^%v
^GlzKl
10.Cytotoxic T lymphocyte, CTL) A $i^/hJs
t3h ){jZ
11.IL-15 and IL-15 receptor (IL-15R) }[R-)M
{A'*3(8
12.MHC restriction f>bL
}L
S
F`(`h0e
13.Affinity-chromatography l6L?jiTl_
l
u8*+.V
14.Cyctosprin A, CsA 7WwE] ^M
I _gE`N
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) wSw> UU
[(gXjt-
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© C}(@cn
`L
rOz1tY)l0d
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 R1D ;
u88wSe<\X
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ vP=68muD
:PtZKt;~X
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ fvcS=nRQv
dI&Q5M8
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© 5mC"8N1)
/isalOT
ÃâÒßѧרҵ£º +[<YE
u*TC8!
n
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ Pc_aEBq
"4;nnq
Ïû»¯ÄÚ¿Æ£º m3TR}=n
:
nQlS
2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ 7jgj;%
Ps74SoD-
ѪҺ²¡Ñ§×¨Òµ£º xC,x_:R`
i=cST8!8N
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿